Tonix Pharmaceuticals Holding Corp (NAS:TNXP)
$ 0.1883 -0.0005 (-0.26%) Market Cap: 35.19 Mil Enterprise Value: 15.65 Mil PE Ratio: 0 PB Ratio: 0.39 GF Score: 31/100

Tonix Pharmaceuticals Holding Corp At The June 1st Virtual Investor Summit Transcript

Jun 01, 2023 / 02:30PM GMT
Release Date Price: $60.16 (+5.03%)
Fred Rockwell
Investor Summit Group - Moderator

Fred Rockwell from Investor Summit, and I'm excited to introduce Jessica Morris, COO of Tonix Pharmaceuticals. Jessica, please take it.

Jessica Morris
Tonix Pharmaceuticals Holding Corp. - COO

Great. Thank you very much for the introduction, and it's great to be here presenting virtually at the Investor Summit Conference today. Good morning to everyone. As stated, I'm Jessica Morris, Chief Operating Officer with Tonix Pharmaceuticals. We are a publicly traded company, traded on Nasdaq under the ticker TNXP. So here as our standard public company disclosure, I will be making forward-looking statements today. And I invite you to view our SEC filings for more complete information.

So Tonix is a clinical-stage biopharmaceutical company. And here we have listed our mission, which is to improve population health by inventing and developing innovative therapies as well as vaccines. And we do this using our in-house capabilities as well as collaborations with other companies and academic institutions to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot